Sidoti Csr Comments on GoHealth’s Q1 Earnings (NASDAQ:GOCO)

GoHealth, Inc. (NASDAQ:GOCOFree Report) – Stock analysts at Sidoti Csr issued their Q1 2026 earnings per share estimates for shares of GoHealth in a research report issued to clients and investors on Wednesday, January 8th. Sidoti Csr analyst J. Sidoti forecasts that the company will post earnings of ($0.65) per share for the quarter. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Sidoti Csr also issued estimates for GoHealth’s Q2 2026 earnings at ($2.73) EPS, Q3 2026 earnings at ($3.41) EPS and Q4 2026 earnings at ($2.04) EPS.

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $13.00 price target on shares of GoHealth in a research report on Monday, October 21st.

Read Our Latest Research Report on GOCO

GoHealth Trading Up 0.3 %

Shares of GOCO stock opened at $14.71 on Friday. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. GoHealth has a 1 year low of $7.27 and a 1 year high of $14.99. The stock has a fifty day moving average of $12.43 and a two-hundred day moving average of $10.94. The firm has a market capitalization of $336.95 million, a PE ratio of -4.20 and a beta of 1.64.

Institutional Trading of GoHealth

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Geode Capital Management LLC raised its stake in shares of GoHealth by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock worth $973,000 after buying an additional 3,205 shares in the last quarter. Empowered Funds LLC raised its stake in shares of GoHealth by 5.1% in the 3rd quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock worth $207,000 after buying an additional 1,072 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of GoHealth by 22.0% in the 2nd quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock worth $178,000 after buying an additional 3,300 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of GoHealth by 16.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company’s stock worth $126,000 after buying an additional 1,802 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of GoHealth by 83.9% in the 3rd quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after buying an additional 4,372 shares in the last quarter. Institutional investors own 24.21% of the company’s stock.

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

See Also

Earnings History and Estimates for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.